Vemurafenib Improves Overall Survival Compared to Dacarbazine in Advanced BRAFV600E-mutated Melanoma: Updated Survival Results From a Phase III Randomised, Open-label, Multicentre Trial / Mcarthur, G; Hauschild, A; Robert, C; Haanen, Jb; Ascierto, P; Lee, Rj; Nolop, K; Nelson, B; Flaherty, Kt; Chapman, Pb. - In: EUROPEAN JOURNAL OF CANCER. - ISSN 0959-8049. - 47:(2011), pp. 14-14.
Vemurafenib Improves Overall Survival Compared to Dacarbazine in Advanced BRAFV600E-mutated Melanoma: Updated Survival Results From a Phase III Randomised, Open-label, Multicentre Trial
Ascierto P;
2011
File in questo prodotto:
Non ci sono file associati a questo prodotto.
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
